Usefulness of biological markers in evaluation of smoking;Intérêt des différents marqueurs biologiques dans l'évaluation du tabagisme

Pathologie Biologie

Volumn 52, Issue 3, 2004, Pages 164-172

  Larramendy, C ^a   Divine C ^a   Asnafi Farhang, S ^a   Lagrue, G ^a  

^a Hopital Albert Chenevier   (France)

Author keywords

Cotinine; Dosage; Markers; Marqueurs; Tabagisme; Tobacco use

Indexed keywords

BIOLOGICAL MARKER; CARBON MONOXIDE; COTININE; NICOTINE; THIOCYANATE;

ACCURACY; ANALYTIC METHOD; BLOOD ANALYSIS; BODY FLUID; CHROMATOGRAPHY; COLORIMETRY; COST BENEFIT ANALYSIS; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; EXPOSURE; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INHALATION; INTERMETHOD COMPARISON; MEASUREMENT; MEDICAL DECISION MAKING; METABOLISM; METABOLITE; PARAMETER; PRESCRIPTION; RADIOIMMUNOASSAY; REVIEW; SALIVA ANALYSIS; SENSITIVITY AND SENSIBILITY; SMOKING; SMOKING HABIT; STANDARDIZATION; TOBACCO; URINALYSIS;

EID: 1842559651     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2003.05.003     Document Type: Article

References (59)

1. Pre J. Les marqueurs du tabagisme. Pathol Biol (Paris). 40:(10):1992;1015-1021.
2. Roussel G., Roche D., Momas I., Brahimi N., Callais F., Lequang N.T., et al. Usefulness of markers in managing tobacco withdrawal. Pathol Biol (Paris). 45:(6):1997;467-471.
3. Sillett R.W., Wilson M.B., Malcolm R.E., Ball K.P. Deception among smokers. Br Med J. 2:(6146):1978;1185-1186.
4. Jarvis M.J., Russell M.A., Saloojee Y. Expired air carbon monoxide: a simple breath test of tobacco smoke intake. Br Med J. 281:(6238):1980;484-485.
5. Wald N.J., Idle M., Boreham J., Bailey A. Carbon monoxide in breath in relation to smoking and carboxyhaemoglobin levels. Thorax. 36:(5):1981;366-369.
6. Prignot J. Quantification and chemical markers of tobacco-exposure. Eur J Respir Dis. 70:(1):1987;1-7.
7. Berlin I., Radzius A., Henningfield J.E., Moolchan E.T. Correlates of expired air carbon monoxide: effect of ethnicity and relationship with saliva cotinine and nicotine. Nicotine Tob Res. 3:(4):2001;325-331.
8. Lagrue G., Mautrait C., Cormier S., Dupont P. Une cause nouvelle de faux positifs dans l'utilisation des analyseurs de CO dans l'air expiré Presse Med. 31:2002;1502-1503.
9. Junge B. Changes in serum thiocyanate concentration on stopping smoking. Br Med J (Clin Res Ed). 291:(6487):1985;22.
10. Densen P.M., Davidow B., Bass H.E., Jones E.W. A chemical test for smoking exposure. Arch Environ Health. 14:(6):1967;865-874.
11. Ngogang J., Eben-Moussi E., Raisonnier A. Le thiocyanate salivaire, urinaire et plasmatique des fumeurs et des non-fumeurs. Pathol Biol (Paris). 31:(3):1983;155-160.
12. Foss O.P., Lund-Larsen P.G. Serum thiocyanate and smoking: interpretation of serum thiocyanate levels observed in a large health study. Scand J Clin Lab Invest. 46:(3):1986;245-251.
13. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 4:(2):2002;149-159.
14. Galanti L.M. Specificity of salivary thiocyanate as marker of cigarette smoking is not affected by alimentary sources. Clin Chem. 43:(1):1997;184-185.
15. Benowitz N.L., Jacob P., Fong I., Gupta S. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther. 268:(1):1994;296-303.
16. Benowitz N.L., Jacob P. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther. 56:(5):1994;483-493.
17. Benowitz N.L., Jacob P. Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers. Clin Pharmacol Ther. 53:(3):1993;316-323.
18. Lagrue G., Philippon C., Lebargy F., Portos J.L., Cormier S. La consommation de certaines solanacées comporte-t-elle un risque d'intoxication nicotinique ? Presse Med. 23:(37):1994;1729-1730.
19. Benowitz N.L., Kuyt F., Jacob P., Jones R.T., Osman A.L. Cotinine disposition and effects. Clin Pharmacol Ther. 34:(5):1983;604-611.
20. Rosa M., Pacifici R., Altieri I., Pichini S., Ottaviani G., Zuccaro P. How the steady-state cotinine concentration in cigarette smokers is directly related to nicotine intake. Clin Pharmacol Ther. 52:(3):1992;324-329.
21. Caraballo R.S., Giovino G.A., Pechacek T.F., Mowery P.D., Richter P.A., Strauss W.J., et al. Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991. Jama. 280:(2):1998;135-139.
22. Thompson S.G., Barlow R.D., Wald N.J., Van Vunakis H. How should urinary cotinine concentrations be adjusted for urinary creatinine concentration? Clin Chim Acta. 187:(3):1990;289-295.
23. Bruckert E., Jacob N., Lamaire L., Truffert J., Percheron F., de Gennes J.L. Relationship between smoking status and serum lipids in a hyperlipidemic population and analysis of possible confounding factors. Clin Chem. 38:(9):1992;1698-1705.
24. Woodward M., Tunstall-Pedoe H., Smith W.C., Tavendale R. Smoking characteristics and inhalation biochemistry in the Scottish population. J Clin Epidemiol. 44:(12):1991;1405-1410.
25. Hagan R.L., Ramos J.M. Jr, Jacob P.M. Increasing urinary cotinine concentrations at elevated temperatures: the role of conjugated metabolites. J Pharm Biomed Anal. 16:(2):1997;191-197.
26. Barlow R.D., Stone R.B., Wald N.J., Puhakainen E.V. The direct barbituric acid assay for nicotine metabolites in urine: a simple colorimetric test for the routine assessment of smoking status and cigarette smoke intake. Clin Chim Acta. 165:(1):1987;45-52.
27. Granella M., Priante E., Nardini B., Bono R., Clonfero E. Excretion of mutagens, nicotine and its metabolites in urine of cigarette smokers. Mutagenesis. 11:(2):1996;207-211.
28. Phung-Koskas T., Le Moel G., Garelik D., Harault C., Durand G. Intoxication tabagique-Dosage de la cotinine urinaire. L'Eurobiologiste. XXXIII:(239):1999;23-29.
29. Parviainen M.T., Puhakainen E.V., Laatikainen R., Savolainen K., Herranen J., Barlow L.D. Nicotine metabolites in the urine of smokers. J Chromatogr. 525:(1):1990;193-202.
30. Smith C.L., Cooke M. Evaluation of diethylthiobarbituric acid as a spectrophotometric reagent for tobacco alkaloids. Analyst. 112:(11):1987;1515- 1518.
31. Smith R.F., Mather H.M., Ellard G.A. Assessment of simple colorimetric procedures to determine smoking status of diabetic subjects. Clin Chem. 44:(2):1998;275-280.
32. Langone J.J., Gjika H.B., Van Vunakis H. Nicotine and its metabolites. Radioimmunoassays for nicotine and cotinine. Biochemistry. 12:(24):1973;5025- 5030.
33. Langone J.J., Van Vunakis H. Radioimmunoassay of nicotine, cotinine, and gamma-(3-pyridyl)-gamma-oxo- N-methylbutyramide. Methods Enzymol. 84:1982;628-640.
34. Zuccaro P., Pichini S., Altieri I., Rosa M., Pellegrini M., Pacifici R. Interference of nicotine metabolites in cotinine determination by RIA. Clin Chem. 43:(1):1997;180-181.
35. Bjercke R.J., Cook G., Rychlik N., Gjika H.B., Van Vunakis H., Langone J.J. Stereospecific monoclonal antibodies to nicotine, cotinine, and their use in enzyme-linked immunosorbent assays. J Immunol Methods. 90:(2):1986;203-213.
36. Langone J.J., Cook G., Bjercke R.J., Lifschitz M.H. Monoclonal antibody Elisa for cotinine in saliva and urine of active and passive smokers. J Immunol Methods. 114:(1-2):1988;73-78.
37. Roche D., Callais F., Reungoat P., Momas I. Adaptation of an enzyme immunoassay to assess urinary cotinine in nonsmokers exposed to tobacco smoke. Clin Chem. 47:(5):2001;950-952.
38. Tyrpien K., Wielkoszynski T., Janoszka B., Dobosz C., Bodzek D., Steplewski Z. Application of liquid separation techniques to the determination of the main urinary nicotine metabolites. J Chromatogr A. 870:(1-2):2000;29-38.
39. James H., Tizabi Y., Taylor R. Rapid method for the simultaneous measurement of nicotine and cotinine in urine and serum by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl. 708:(1-2):1998;87-93.
40. Baskin L.B., Anderson R.W., Charlson J.R., Hurt R.D., Lawson G.M. A solid phase extraction method for determination of nicotine in serum and urine by isotope dilution gas chromatography/mass spectrometry with selected ion monitoring. Ann Clin Biochem. 35:(Pt 4):1998;522-527.
41. Zuccaro P., Altieri I., Rosa M., Passa A.R., Pichini S., Ricciarello G., et al. Determination of nicotine and four metabolites in the serum of smokers by high-performance liquid chromatography with ultraviolet detection. J Chromatogr. 621:(2):1993;257-261.
42. Tuomi T., Johnsson T., Reijula K. Analysis of nicotine, 3-hydroxycotinine, cotinine, and caffeine in urine of passive smokers by HPLC-tandem mass spectrometry. Clin Chem. 45:(12):1999;2164-2172.
43. Pichini S., Altieri I., Pacifici R., Rosa M., Ottaviani G., Zuccaro P. Simultaneous determination of cotinine and trans-3'-hydroxycotinine in human serum by high-performance liquid chromatography. J Chromatogr. 577:(2):1992;358-361.
44. Oddoze C., Pauli A.M., Pastor J. Rapid and sensitive high-performance liquid chromatographic determination of nicotine and cotinine in nonsmoker human and rat urines. J Chromatogr B Biomed Sci Appl. 708:(1-2):1998;95-101.
45. Thuan N.T., Migueres M.L., Roche D., Roussel G., Mahuzier G., Chretien J., et al. Elimination of caffeine interference in HPLC determination of urinary nicotine and cotinine. Clin Chem. 35:(7):1989;1456-1459.
46. Pichini S., Altieri I., Pacifici R., Rosa M., Zuccaro P. Elimination of caffeine interference in high-performance liquid chromatographic determination of cotinine in human plasma. J Chromatogr. 568:(1):1991;267-269.
47. Berny C., Boyer J.C., Capolaghi B., L'Homme G.D., Desch G., Garelik D., et al. Les marqueurs spécifiques du tabagisme. Ann Biol Clin. 60:(3):2002;263-272.
48. Zuccaro P., Altieri I., Rosa M., Passa A.R., Pichini S., Pacifici R. Solid-phase extraction of nicotine and its metabolites for high- performance liquid chromatographic determination in urine. J Chromatogr B Biomed Appl. 668:(1):1995;187-188.
49. Jacob P., Yu L., Shulgin A.T., Benowitz N.L. Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes. Am J Public Health. 89:(5):1999;731-736.
50. Gueguen C., Lagrue G., Janse-Marec J. Effect of smoking on the fetus and the child during pregnancy. J Gynecol Obstet Biol Reprod. 24:(8):1995;853-859.
51. Schulte-Hobein B., Schwarts-Bibkenbach D., Abt S., Plum C., Nam H. Cigarette smoke exposure and development of infants throughout the first year of life: influence of passive smoking and nursing on cotinine levels in breast milk and infant's urine. Acta Paediatr. 81:1992;550-557.
52. Leong J.W., Dore N.D., Shelley K., Holt E.J., Laing I.A., Palmer L.J., et al. The elimination half-life of urinary cotinine in children of tobacco-smoking mothers. Pulmonary Pharmacology & Therapeutics. 11:1998;287-290.
53. Jordaan E.R., Ehrlich R.I., Potter P. Environmental tobacco smoke exposure in children: household and community determinants. Arch Environ Health. 54:(5):1999;319-327.
54. de L'Homme G., Jacob N., Mallet A., Derenne J.P. Les outils d'évaluation de la dépendance tabagique : comparaison des questionnaires et des dosages de marqueurs. Pathol Biol. 43:(7):1995;611-617.
55. Lombardo T.W., Hughes J.R., Fross J.D. Failure to support the validity of the Fagerstrom Tolerance Questionnaire as a measure of physiological tolerance to nicotine. Addict Behav. 13:(1):1988;87-90.
56. Lagrue G., Dupont P., Fakhfakh R., Mautrait C., Cormier S. Le traitement de substitution nicotinique dix ans après. Presse Med. 31:(7):2002;291-295.
57. Benowitz N.L., Jacob P., Kozlowski L.T., Yu L. Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide. N Engl J Med. 315:(21):1986;1310-1313.
58. Fagerström K.O., Hughes J.R. Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: a review. Nicotine Tob Res. 2002;S73-S79.
59. Lagrue G, Le Foll B. Tabagisme et BPCO: les conclusions de la Lung Health Study. AER; 3(27).